Disruption of CTCF/cohesin-mediated high-order chromatin structures by DNA methylation downregulates PTGS2 expression

Oncogene

Volumn 34, Issue 45, 2015, Pages 5677-5684

  Kang, J Y ^a,b   Song, S H ^a   Yun, J ^a,b   Jeon, M S ^a,b   Kim, H P ^a   Han, S W ^a,c   Kim, T Y ^a,b,c  

^a Seoul National University   (South Korea)

^b Seoul National University   (South Korea)

^c Seoul National University Hospital   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

OXYGENASE; PROSTAGLANDIN SYNTHASE 2; TRANSCRIPTION FACTOR CTCF; UNCLASSIFIED DRUG; CCCTC-BINDING FACTOR; CELL CYCLE PROTEIN; CHROMATIN; COHESIN; CYCLOOXYGENASE 2; NONHISTONE PROTEIN; PTGS2 PROTEIN, HUMAN; REPRESSOR PROTEIN; TUMOR PROTEIN;

ARTICLE; CARCINOGENESIS; CHROMATIN STRUCTURE; CPG ISLAND; DNA METHYLATION; GENE EXPRESSION; GENE LOCUS; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; RECEPTOR DOWN REGULATION; BIOSYNTHESIS; CHROMATIN; DOWN REGULATION; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; NEOPLASM; PATHOLOGY; TUMOR CELL LINE;

CELL CYCLE PROTEINS; CELL LINE, TUMOR; CHROMATIN; CHROMOSOMAL PROTEINS, NON-HISTONE; CPG ISLANDS; CYCLOOXYGENASE 2; DNA METHYLATION; DOWN-REGULATION; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; NEOPLASM PROTEINS; NEOPLASMS; REPRESSOR PROTEINS;

EID: 84947031445     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2015.17     Document Type: Article

References (45)

1. de Wit E, Bouwman BA, Zhu Y, Klous P, Splinter E, Verstegen MJ et al. The pluripotent genome in three dimensions is shaped around pluripotency factors. Nature 2013; 501: 227-231.
2. Nagano T, Lubling Y, Stevens TJ, Schoenfelder S, Yaffe E, Dean W et al. Single-cell Hi-C reveals cell-Do-cell variability in chromosome structure. Nature 2013; 502: 59-64.
3. Phillips-Cremins JE, Sauria ME, Sanyal A, Gerasimova TI, Lajoie BR, Bell JS et al. Architectural protein subclasses shape 3D organization of genomes during lineage commitment. Cell 2013; 153: 1281-1295.
4. Schoenfelder S, Sexton T, Chakalova L, Cope NF, Horton A, Andrews S et al. Preferential associations between co-regulated genes reveal a transcriptional interactome in erythroid cells. Nat Genet 2010; 42: 53-61.
5. Ong CT, Corces VG. CTCF: an architectural protein bridging genome topology and function. Nat Rev Genet 2014; 15: 234-246.
6. Krivega I, Dean A. Enhancer and promoter interactions-long distance calls. Curr Opin Genet Dev 2012; 22: 79-85.
7. DeMare LE, Leng J, Cotney J, Reilly SK, Yin J, Sarro R et al. The genomic landscape of cohesin-Associated chromatin interactions. Genome Res 2013; 23: 1224-1234.
8. Parelho V, Hadjur S, Spivakov M, Leleu M, Sauer S, Gregson HC et al. Cohesins functionally associate with CTCF on mammalian chromosome arms. Cell 2008; 132: 422-433.
9. Rubio ED, Reiss DJ, Welcsh PL, Disteche CM, Filippova GN, Baliga NS et al. CTCF physically links cohesin to chromatin. Proc Natl Acad Sci USA 2008; 105: 8309-8314.
10. Dorsett D, Strom L. The ancient and evolving roles of cohesin in gene expression and DNA repair. Curr Biol 2012; 22: R240-R250.
11. Schaaf CA, Kwak H, Koenig A, Misulovin Z, Gohara DW, Watson A et al. Genome-wide control of RNA polymerase II activity by cohesin. PLoS Genet 2013; 9: e1003382.
12. Seitan V, Faure A, Zhan Y, McCord R, Lajoie B, Ing-Simmons E et al. Cohesin-based chromatin interactions enable regulated gene expression within pre-existing architectural compartments. Genome Res 2013; 23: 2066-2077.
13. Yan J, Enge M, Whitington T, Dave K, Liu J, Sur I et al. Transcription factor binding in human cells occurs in dense clusters formed around cohesin anchor sites. Cell 2013; 154: 801-813.
14. Baylin SB, Jones PA. A decade of exploring the cancer epigenome-biological and translational implications. Nat Rev Cancer 2011; 11: 726-734.
15. Rodriguez-Paredes M, Esteller M. Cancer epigenetics reaches mainstream oncology. Nat Med 2011; 17: 330-339.
16. Jin B, Robertson KD. DNA methyltransferases, DNA damage repair, and cancer. Adv Exp Med Biol 2013; 754: 3-29.
17. Bell AC, Felsenfeld G. Methylation of a CTCF-dependent boundary controls imprinted expression of the Igf2 gene. Nature 2000; 405: 482-485.
18. Kanduri C, Pant V, Loukinov D, Pugacheva E, Qi CF, Wolffe A et al. Functional association of CTCF with the insulator upstream of the H19 gene is parent of origin-specific and methylation-sensitive. Curr Biol 2000; 10: 853-856.
19. Stadler MB, Murr R, Burger L, Ivanek R, Lienert F, Scholer A et al. DNA-binding factors shape the mouse methylome at distal regulatory regions. Nature 2011; 480: 490-495.
20. Batlle-Lopez A, Cortiguera MG, Rosa-Garrido M, Blanco R, Del Cerro E, Torrano V et al. Novel CTCF binding at a site in exon1A of BCL6 is associated with active histone marks and a transcriptionally active locus. Oncogene 2013; 34: 246-256.
21. Chang J, Zhang B, Heath H, Galjart N, Wang X, Milbrandt J. Nicotinamide adenine dinucleotide (NAD)-regulated DNA methylation alters CCCTC-binding factor (CTCF)/cohesin binding and transcription at the BDNF locus. Proc Natl Acad Sci USA 2010; 107: 21836-21841.
22. Lai AY, Fatemi M, Dhasarathy A, Malone C, Sobol SE, Geigerman C et al. DNA methylation prevents CTCF-mediated silencing of the oncogene BCL6 in B cell lymphomas. J Exp Med 2010; 207: 1939-1950.
23. Rodriguez C, Borgel J, Court F, Cathala G, Forne T, Piette J. CTCF is a DNA methylation-sensitive positive regulator of the INK/ARF locus. Biochem Biophys Res Commun 2010; 392: 129-134.
24. Wang D, Dubois RN. Eicosanoids and cancer. Nat Rev Cancer 2010; 10: 181-193.
25. Song SH, Jong HS, Choi HH, Inoue H, Tanabe T, Kim NK et al. Transcriptional silencing of Cyclooxygenase-2 by hyper-methylation of the 5' CpG island in human gastric carcinoma cells. Cancer Res 2001; 61: 4628-4635.
26. Toyota M, Shen L, Ohe-Doyota M, Hamilton SR, Sinicrope FA, Issa JP. Aberrant methylation of the Cyclooxygenase 2 CpG island in colorectal tumors. Cancer Res 2000; 60: 4044-4048.
27. de Maat MF, van de Velde CJ, Umetani N, de Heer P, Putter H, van Hoesel AQ et al. Epigenetic silencing of cyclooxygenase-2 affects clinical outcome in gastric cancer. J Clin Oncol 2007; 25: 4887-4894.
28. Heintzman ND, Stuart RK, Hon G, Fu Y, Ching CW, Hawkins RD et al. Distinct and predictive chromatin signatures of transcriptional promoters and enhancers in the human genome. Nat Genet 2007; 39: 311-318.
29. Hadjur S, Williams LM, Ryan NK, Cobb BS, Sexton T, Fraser P et al. Cohesins form chromosomal cis-interactions at the developmentally regulated IFNG locus. Nature 2009; 460: 410-413.
30. Hou C, Dale R, Dean A. Cell type specificity of chromatin organization mediated by CTCF and cohesin. Proc Natl Acad Sci USA 2010; 107: 3651-3656.
31. Murrell A, Heeson S, Reik W. Interaction between differentially methylated regions partitions the imprinted genes Igf2 and H19 into parent-specific chromatin loops. Nat Genet 2004; 36: 889-893.
32. Dekker J, Rippe K, Dekker M, Kleckner N. Capturing chromosome conformation. Science 2002; 295: 1306-1311.
33. Yun J, Song SH, Park J, Kim HP, Yoon YK, Lee KH et al. Gene silencing of EREG mediated by DNA methylation and histone modification in human gastric cancers. Lab Invest 2012; 92: 1033-1044.
34. Coward WR, Feghali-Bostwick CA, Jenkins G, Knox AJ, Pang L. A central role for G9a and EZH2 in the epigenetic silencing of cyclooxygenase-2 in idiopathic pulmonary fibrosis. FASEB J 2014; 28: 3183-3196.
35. Easwaran H, Johnstone SE, Van Neste L, Ohm J, Mosbruger T, Wang Q et al. A DNA hypermethylation module for the stem/progenitor cell signature of cancer. Genome Res 2012; 22: 837-849.
36. McGarvey KM, Van Neste L, Cope L, Ohm JE, Herman JG, Van Criekinge W et al. Defining a chromatin pattern that characterizes DNA-hypermethylated genes in colon cancer cells. Cancer Res 2008; 68: 5753-5759.
37. Nitzsche A, Paszkowski-Rogacz M, Matarese F, Janssen-Megens EM, Hubner NC, Schulz H et al. RAD21 cooperates with pluripotency transcription factors in the maintenance of embryonic stem cell identity. PloS One 2011; 6: e19470.
38. Gilroy DW, Saunders MA, Sansores-Garcia L, Matijevic-Aleksic N, Wu KK. Cell cycledependent expression of cyclooxygenase-2 in human fibroblasts. FASEB J 2001; 15: 288-290.
39. Wendt KS, Yoshida K, Itoh T, Bando M, Koch B, Schirghuber E et al. Cohesin mediates transcriptional insulation by CCCTC-binding factor. Nature 2008; 451: 796-801.
40. Egloff S, Dienstbier M, Murphy S. Updating the RNA polymerase CTD code: adding gene-specific layers. Trends Genet 2012; 28: 333-341.
41. Rhodes JM, McEwan M, Horsfield JA. Gene regulation by cohesin in cancer: is the ring an unexpected party to proliferation? Mol Cancer Res 2011; 9: 1587-1607.
42. Rizzo MT. Cyclooxygenase-2 in oncogenesis. Clin Chim Acta 2011; 412: 671-687.
43. Song SH, Hou C, Dean A. A positive role for NLI/Ldb1 in long-range beta-globin locus control region function. Mol Cell 2007; 28: 810-822.
44. Gomes NP, Espinosa JM. Gene-specific repression of the p53 target gene PUMA via intragenic CTCF-Cohesin binding. Genes Dev 2010; 24: 1022-1034.
45. Tolhuis B, Palstra RJ, Splinter E, Grosveld F, de Laat W. Looping and interaction between hypersensitive sites in the active beta-globin locus. Mol Cell 2002; 10: 1453-1465.